| Jul 9 |
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
|
| Jun 24 |
What's Going On With Regulus Therapeutics Stock Monday?
|
| Jun 24 |
Regulus Therapeutics Announces Positive Topline Data from the Third Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
| Jun 14 |
Regulus Therapeutics Inc.'s (NASDAQ:RGLS) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week
|
| Jun 4 |
Regulus Therapeutics Announces Expected Addition to the Russell 3000® and Russell 2000® Indexes
|
